Timetable: Annual reassessment - ATMP
Timetable: Annual reassessment - ATMP
Timetable: Annual reassessment - ATMP
Timetable: Annual renewal application of conditional marketing authorisation - ATMP
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 14-17 October 2024
List of medicines currently in PRIME scheme
Timetable: Marketing authorisation renewal application - ATMP
Timetable: Type II variation and worksharing application assessment - ATMP
Timetable: Type IB variation requiring linguistic review
Presentation - Product Management Service (PMS) Product UI training (access and navigation)
Human medicines European public assessment report (EPAR): Memantine LEK, memantine, Date of authorisation: 21/04/2013, Date of refusal: 21/02/2013, Revision: 5, Status: Withdrawn (authorisation)
List of European Union reference dates and frequency of submission of periodic safety update reports (PSURs)